Indication · GI, Urology & Nephrology
Fecal incontinence and constipation
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
74
Cleared or approved since 2000
PMA and De Novo
25
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
178
1,365 device trials in all
Devices
74 devices. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- InterStim Therapy System, Verify Evaluation System
Medtronic Neuromodulation · PMA · Stimulator, Electrical, Implantable, For Incontinence · newest 2025 · 29 decisions
- Axonics Sacral Neuromodulation System
Boston Scientific Corporation · PMA · Stimulator, Electrical, Implantable, For Incontinence · newest 2026 · 22 decisions
- Axonics Sacral Neuromodulation System
Boston Scientific Corporation · PMA · Implanted Electrical Device Intended For Treatment Of Fecal Incontinence · newest 2026 · 22 decisions
57 more devices with a free account
Showing the first 60. Narrow by pathway, or open a device type below.
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Feasibility of the Maastro Applicator in Rectal CancerActive, not recruiting
Maastricht Radiation OncologyAcademic, hospital or other
NCT06087718 · 10 participants (planned) · Start Aug 27, 2024 · Primary completion Oct 6, 2025
Device: Maastro applicator · For: Rectal Cancer; Feasibility; Toxicity and 5 more
Sites: Maastricht, Netherlands
Medtronic - MITGPublic (MDT)
NCT07351071 · 137 participants (planned) · Start Dec 30, 2025 · Primary completion Apr 30, 2027
Device: Signia™ circular stapler with Tri-Staple™ Technology (Signia™ Circular Stapling system) · For: Colorectal Anastomosis; Left-sided Colon Resection; Anastomotic Leak and 8 more
Sites: New Haven, Connecticut; Tampa, Florida; Marietta, Georgia · 11 sites in all
- VR Therapies for IBDEnrolling by invitation
Brennan SpiegelAcademic, hospital or other
NCT07590518 · 76 participants (planned) · Start Sep 29, 2026 · Primary completion Jun 2027
Device: Distraction VR; VR/AI CBT · For: Inflammatory Bowel Disease (IBD); Ulcerative Colitis (UC); Crohn Disease (CD) and 1 more
Sites: Los Angeles, California; Chicago, Illinois
1,362 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
- System, Gastrointestinal Motility (Electrical) (FFX)32
- Stimulator, Electrical, Implantable, For Incontinence (EZW)12
- Monitor, Esophageal Motility, Anorectal Motility, And Tube (KLA)11
- Implanted Electrical Device Intended For Treatment Of Fecal Incontinence (QON)7
- Implanted Fecal Incontinence Device (MIP)3
- Gastrointestinal Motility System, Capsule (NYV)3
- Rectal Insert (PBP)2
- Mesh, Surgical, Collagen, Fistula (OXN)1
- Dynamic Rectal Control System (PJH)1
- Orally Ingested Transient Device For Constipation (QTN)1
- Powered Fecal Management System (SJB)1
Research
- Device studies on fecal incontinence across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.